Literature DB >> 23628225

Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.

P Marco Fisichella1, Christopher S Davis, Erin Lowery, Luis Ramirez, Richard L Gamelli, Elizabeth J Kovacs.   

Abstract

BACKGROUND: We hypothesized that immune mediator concentrations in the bronchoalveolar fluid (BALF) are predictive of bronchiolitis obliterans syndrome (BOS) and demonstrate specific patterns of dysregulation, depending on the presence of acute cellular rejection, BOS, aspiration, and timing of lung transplantation. STUDY
DESIGN: We prospectively collected 257 BALF samples from 105 lung transplant recipients. The BALF samples were assessed for absolute and differential white blood cell counts and 34 proteins implicated in pulmonary immunity, inflammation, fibrosis, and aspiration.
RESULTS: There were elevated BALF concentrations of interleukin (IL)-15, IL-17, basic fibroblast growth factor, tumor necrosis factor-α, and myeloperoxidase, and reduced concentrations of α1-antitrypsin, which were predictive of early-onset BOS. Patients with BOS had an increased percentage of BALF lymphocytes and neutrophils, with a reduced percentage of macrophages (p < 0.05). The BALF concentrations of IL-1β; IL-8; interferon-γ-induced protein 10; regulated upon activation, normal T-cell expressed and secreted; neutrophil elastase; and pepsin were higher in patients with BOS (p < 0.05). Among those with BOS, BALF concentrations of IL-1RA; IL-8; eotaxin; interferon-γ-induced protein 10; regulated upon activation, normal T-cell expressed and secreted; myeloperoxidase; and neutrophil elastase were positively correlated with time since transplantation (p < 0.01). Those with worse grades of acute cellular rejection had an increased percentage of lymphocytes in their BALF (p < 0.0001) and reduced BALF concentrations of IL-1β, IL-7, IL-9, IL-12, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, interferon-γ, and vascular endothelial growth factor (p ≤ 0.001). Patients with aspiration based on detectable pepsin had increased percentage of neutrophils (p < 0.001) and reduced BALF concentrations of IL-12 (p < 0.001).
CONCLUSIONS: The BALF levels of IL-15, IL-17, basic fibroblast growth factor, tumor necrosis factor-α, myeloperoxidase, and α1-antitrypsin at 6 to 12 months after lung transplantation are predictive of early-onset BOS, and those with BOS and aspiration have an augmented chemotactic and inflammatory balance of pulmonary leukocytes and immune mediators. These data justify the surgical prevention of aspiration and argue for the refinement of antirejection regimens.
Copyright © 2013 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23628225      PMCID: PMC4135482          DOI: 10.1016/j.jamcollsurg.2013.03.008

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  38 in total

Review 1.  Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.

Authors:  Marc Estenne; Janet R Maurer; Annette Boehler; James J Egan; Adaani Frost; Marshall Hertz; George B Mallory; Gregory I Snell; Samuel Yousem
Journal:  J Heart Lung Transplant       Date:  2002-03       Impact factor: 10.247

2.  Laparoscopic antireflux surgery in the lung transplant population.

Authors:  C L Lau; S M Palmer; D N Howell; R McMahon; D Hadjiliadis; J Gaca; T N Pappas; R D Davis; S Eubanks
Journal:  Surg Endosc       Date:  2002-07-29       Impact factor: 4.584

3.  Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.

Authors:  G C Riise; B A Andersson; C Kjellström; G Martensson; F N Nilsson; W Ryd; H Scherstén
Journal:  Eur Respir J       Date:  1999-11       Impact factor: 16.671

4.  Pulmonary immune changes early after laparoscopic antireflux surgery in lung transplant patients with gastroesophageal reflux disease.

Authors:  P Marco Fisichella; Christopher S Davis; Erin Lowery; Matthew Pittman; James Gagermeier; Robert B Love; Elizabeth J Kovacs
Journal:  J Surg Res       Date:  2012-04-18       Impact factor: 2.192

5.  Neutrophils, unopposed neutrophil elastase, and alpha1-antiprotease defenses following human lung transplantation.

Authors:  K C Meyer; D R Nunley; J H Dauber; A T Iacono; R J Keenan; R D Cornwell; R B Love
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

6.  Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.

Authors:  J Lieberman
Journal:  Chest       Date:  2000-11       Impact factor: 9.410

7.  Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation.

Authors:  J W Salter; C F Krieglstein; A C Issekutz; D N Granger
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-12       Impact factor: 4.052

8.  Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration.

Authors:  Martine Reynaud-Gaubert; Valerie Marin; Xavier Thirion; Catherine Farnarier; Pascal Thomas; Monique Badier; Pierre Bongrand; Roger Giudicelli; Pierre Fuentes
Journal:  J Heart Lung Transplant       Date:  2002-07       Impact factor: 10.247

9.  Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events.

Authors:  James K Stoller; Robert Fallat; Mark D Schluchter; Ralph G O'Brien; Jason T Connor; Nicholas Gross; Kevin O'Neil; Robert Sandhaus; Ronald G Crystal
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

10.  Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.

Authors:  R Duane Davis; Christine L Lau; Steve Eubanks; Robert H Messier; Denis Hadjiliadis; Mark P Steele; Scott M Palmer
Journal:  J Thorac Cardiovasc Surg       Date:  2003-03       Impact factor: 5.209

View more
  16 in total

1.  Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Authors:  Craig J Galbán; Jennifer L Boes; Maria Bule; Carrie L Kitko; Daniel R Couriel; Timothy D Johnson; Vihba Lama; Eef D Telenga; Maarten van den Berge; Alnawaz Rehemtulla; Ella A Kazerooni; Michael J Ponkowski; Brian D Ross; Gregory A Yanik
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-18       Impact factor: 5.742

2.  Pre-lung transplant measures of reflux on impedance are superior to pH testing alone in predicting early allograft injury.

Authors:  Wai-Kit Lo; Robert Burakoff; Hilary J Goldberg; Natan Feldman; Walter W Chan
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

3.  The Intersection of GERD, Aspiration, and Lung Transplantation.

Authors:  Marco G Patti; Marcelo F Vela; David D Odell; Joel E Richter; P Marco Fisichella; Michael F Vaezi
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2016-05-24       Impact factor: 1.878

4.  Proton Pump Inhibitors Independently Protect Against Early Allograft Injury or Chronic Rejection After Lung Transplantation.

Authors:  Wai-Kit Lo; Hilary J Goldberg; Steve Boukedes; Robert Burakoff; Walter W Chan
Journal:  Dig Dis Sci       Date:  2017-11-01       Impact factor: 3.199

5.  Both Pre-Transplant and Early Post-Transplant Antireflux Surgery Prevent Development of Early Allograft Injury After Lung Transplantation.

Authors:  Wai-Kit Lo; Hilary J Goldberg; Jon Wee; P Marco Fisichella; Walter W Chan
Journal:  J Gastrointest Surg       Date:  2016-01       Impact factor: 3.452

Review 6.  The pulmonary side of reflux disease: from heartburn to lung fibrosis.

Authors:  Marco E Allaix; P Marco Fisichella; Imre Noth; Bernardino M Mendez; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-04-25       Impact factor: 3.452

7.  Usefulness of pH monitoring in predicting the survival status of patients with scleroderma awaiting lung transplantation.

Authors:  Piero Marco Fisichella; Nicholas P Reder; James Gagermeier; Elizabeth J Kovacs
Journal:  J Surg Res       Date:  2014-03-15       Impact factor: 2.192

8.  Pepsin concentrations are elevated in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis after lung transplantation.

Authors:  Christopher S Davis; Bernardino M Mendez; Diana V Flint; Karen Pelletiere; Erin Lowery; Luis Ramirez; Robert B Love; Elizabeth J Kovacs; P Marco Fisichella
Journal:  J Surg Res       Date:  2013-06-29       Impact factor: 2.192

9.  Early extracellular matrix changes are associated with later development of bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Catharina Müller; Annika Andersson-Sjöland; Hans Henrik Schultz; Leif T Eriksson; Claus B Andersen; Martin Iversen; Gunilla Westergren-Thorsson
Journal:  BMJ Open Respir Res       Date:  2017-04-12

Review 10.  Role of gastroesophageal reflux disease in lung transplantation.

Authors:  Kelly E Hathorn; Walter W Chan; Wai-Kit Lo
Journal:  World J Transplant       Date:  2017-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.